title: Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema.
authors.affiliation: Novartis Consumer Health SA, PO Box 269, 1260-1, Nyon, Switzerland. john.magnette@ch.novartis.com
authors.forename: J-L
authors.initials: JL
authors.lastname: Magnette
authors.forename: J-L
authors.initials: JL
authors.lastname: Kienzler
authors.forename: D
authors.initials: D
authors.lastname: Sallin
authors.forename: C
authors.initials: C
authors.lastname: Ménart
authors.forename: F
authors.initials: F
authors.lastname: Nollevaux
authors.forename: A
authors.initials: A
authors.lastname: Knops
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019540:Area Under Curve; D004008:Diclofenac / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004334:Drug Administration Schedule; D004890:Erythema / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy; D014466:Ultraviolet Rays
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004008:Diclofenac